News In Brief
This article was originally published in The Silver Sheet
Executive Summary
Eight new offices established within ORA; FDA moves ahead with post-market surveillance initiatives.
You may also be interested in...
News In Brief
ISO 13485 will be baseline for IMDRF single-audit work plan; U.S. Marshals seize ultrasound gel made by Pharmaceutical Innovations ISO 13485 will be baseline for IMDRF single-audit work plan.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.